These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8671572)

  • 1. False positive tests for anti-hepatitis C antibodies and the problem of notifying blood donors.
    Bar-Shany S; Green MS; Shinar E
    Int J Epidemiol; 1996 Jun; 25(3):674-8. PubMed ID: 8671572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-specific and specific anti-HCV results correlated to age, sex, transaminase, rhesus blood group and follow-up in blood donors.
    Caspari G; Gerlich WH; Beyer J; Schmitt H
    Arch Virol; 1997; 142(3):473-89. PubMed ID: 9349294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age, sex and transaminase dependency of specific and nonspecific results from enzyme immunoassays for antibodies to hepatitis C virus and follow-up of blood donors.
    Caspari G; Gerlich WH; Beyer J; Schmitt H
    Infusionsther Transfusionsmed; 1995 Aug; 22(4):208-19. PubMed ID: 7496119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of clinical and laboratory aspects of antibody tests for detection of hepatitis C virus infection in blood donors and recipients from a low-risk population.
    MacDonald KL; Mills WA; Wood RC; Hanson M; Kline W; Bowman RJ; Polesky HF; Williams AE; Osterholm MT
    Transfusion; 1994 Mar; 34(3):202-8. PubMed ID: 8146891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to hepatitis C virus in autologous blood donors.
    Conover PT; Fang CT; Lam E; Hirschler NV; Jackson JB; Yomtovian RA
    Transfusion; 1991 Sep; 31(7):616-9. PubMed ID: 1654002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
    Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
    Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-generation anti-HCV tests predict infectivity.
    Larsen J; Skaug K; Maeland A
    Vox Sang; 1992; 63(1):39-42. PubMed ID: 1384236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme immunoassays for anti-hepatitis C virus antibodies improved specificity and analytical sensitivity by combination of three different recombinant viral proteins in second generation tests.
    Prohaska W; Schroeter E; Kaars-Wiele P; Kleesiek K
    Eur J Clin Chem Clin Biochem; 1992 Jul; 30(7):397-404. PubMed ID: 1381965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antibody to hepatitis C virus by second-generation enzyme immunoassay.
    Chaudhary RK; Maclean C
    Am J Clin Pathol; 1993 Jun; 99(6):702-4. PubMed ID: 7686716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of antibodies to hepatitis C virus in blood donors and their relationship to surrogate markers.
    Hugo T; Wüst T; Beeser HP
    Beitr Infusionsther; 1992; 30():49-52. PubMed ID: 1284765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rate of false positives in blood donor screening for antibodies to hepatitis C virus. Cause of underestimation of virus transmission rate?
    Prohaska W; Wolff C; Lechler E; Kleesiek K
    Klin Wochenschr; 1991 May; 69(7):294-6. PubMed ID: 1712414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood donors who are repeatedly reactive for hepatitis C virus on enzyme immunoassay and positive on recombinant immunoblot assay: evidence of failure to identify some risk factors.
    Moore SB; Kruger JR; Rakela J; Vamvakas EC; Schimek C; Germer JJ; Persing DH
    Transfusion; 1995 Apr; 35(4):308-12. PubMed ID: 7701548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High proportion of false positive reactions among donors with anti-HCV antibodies in a low prevalence area.
    Sakugawa H; Nakasone H; Nakayoshi T; Kinjo F; Saito A; Yakabi S; Zukeran H; Miyagi Y; Taira R; Koja K
    J Med Virol; 1995 Aug; 46(4):334-8. PubMed ID: 7595410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and comparison of three different anti-hepatitis C virus antibody tests based on chemiluminescence and enzyme-linked immunosorbent assay methods used in the diagnosis of hepatitis C infections in Turkey.
    Kesli R; Ozdemir M; Kurtoglu MG; Baykan M; Baysal B
    J Int Med Res; 2009; 37(5):1420-9. PubMed ID: 19930846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation of second generation anti-hepatitis C virus enzyme immunoassays by antigenic cross-validation.
    Teo CG; Gabriel FG; Mortimer PP
    J Clin Pathol; 1992 Oct; 45(10):917-20. PubMed ID: 1331199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
    Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
    Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin preparations from hepatitis C antibody-positive plasma donors: influence on diagnosis and risk of infection in heart transplant recipients.
    Prohaska W; Wolff C; Schlüter K; Köster-Eiserfunke W; Körner MM; Kleesiek K
    Clin Investig; 1992 Jul; 70(7):573-8. PubMed ID: 1327328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of antibodies against hepatitis C virus in rheumatoid arthritis. Study using second-generation tests].
    Marson P; Vicarioto M; Cavasin F; Volante D; De Silvestro G
    Recenti Prog Med; 1991 Dec; 82(12):679-81. PubMed ID: 1667711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.